British Bioinformatics Co. Pens Peptide Deal with Dartmouth | GenomeWeb

NEW YORK, Sept. 18 – British bioinformatics company Proteom announced Tuesday a collaboration with Dartmouth Medical School to identify and develop peptides that can interrupt the process of apoptosis.

Under the terms of the deal, Proteom will contribute its expertise in designing peptides, while Dartmouth will provide its knowledge about the protein pathways involved in cell death.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.